Inhibitory_JJ
effect_NN
of_IN
growth_NN
hormone_NN
on_IN
TNF-alpha_NN
secretion_NN
and_CC
nuclear_JJ
factor-kappaB_NN
translocation_NN
in_IN
lipopolysaccharide-stimulated_JJ
human_JJ
monocytes_NNS
._.

Several_JJ
studies_NNS
have_VBP
pointed_VBN
to_TO
a_DT
link_NN
between_IN
immune_JJ
and_CC
endocrine_JJ
systems_NNS
,_,
including_VBG
a_DT
regulatory_JJ
function_NN
of_IN
GH_NN
on_IN
monocyte_NN
activation_NN
._.

The_DT
present_JJ
study_NN
demonstrates_VBZ
that_IN
human_JJ
THP-1_NN
promonocytic_JJ
cells_NNS
,_,
engineered_VBN
by_IN
gene_NN
transfer_NN
to_TO
constitutively_RB
produce_VB
human_JJ
growth_NN
hormone_NN
-LRB-_-LRB-
hGH_NN
-RRB-_-RRB-
,_,
secreted_VBD
depressed_JJ
amounts_NNS
of_IN
TNF-alpha_NN
in_IN
response_NN
to_TO
challenge_NN
by_IN
LPS_NN
._.

The_DT
effect_NN
of_IN
GH_NN
appears_VBZ
to_TO
occur_VB
in_IN
an_DT
autocrine_JJ
fashion_NN
,_,
since_IN
the_DT
inhibitory_JJ
effect_NN
on_IN
TNF-alpha_NN
secretion_NN
by_IN
constitutive_JJ
GH_NN
production_NN
could_MD
be_VB
abolished_VBN
in_IN
the_DT
presence_NN
of_IN
anti-hGH_JJ
mAb_NN
._.

The_DT
GH-induced_JJ
inhibitory_JJ
effect_NN
was_VBD
also_RB
observed_VBN
using_VBG
normal_JJ
human_JJ
monocytes_NNS
and_CC
monocyte-derived_JJ
macrophages_NNS
._.

Inhibition_NN
of_IN
TNF-alpha_NN
production_NN
by_IN
THP-1-hGH-transfected_JJ
cells_NNS
cultured_VBN
in_IN
the_DT
presence_NN
of_IN
LPS_NN
is_VBZ
dependent_JJ
on_IN
a_DT
selective_JJ
pathway_NN
,_,
since_IN
no_DT
inhibition_NN
of_IN
TNF-alpha_NN
production_NN
was_VBD
observed_VBN
when_WRB
cells_NNS
were_VBD
cultured_VBN
in_IN
the_DT
presence_NN
of_IN
PMA_NN
._.

Inhibition_NN
of_IN
TNF-alpha_NN
secretion_NN
by_IN
LPS-stimulated_JJ
THP-1-hGH_NN
cells_NNS
was_VBD
associated_VBN
with_IN
a_DT
decrease_NN
in_IN
nuclear_JJ
translocation_NN
of_IN
nuclear_JJ
factor-kappaB_NN
._.

The_DT
capacity_NN
of_IN
GH_NN
to_TO
inhibit_VB
LPS-induced_JJ
TNF-alpha_NN
production_NN
by_IN
monocytes_NNS
without_IN
altering_VBG
other_JJ
pathways_NNS
leading_VBG
to_TO
TNF-alpha_NN
production_NN
may_MD
be_VB
of_IN
potential_JJ
relevance_NN
in_IN
septic_JJ
shock_NN
,_,
since_IN
GH_NN
is_VBZ
available_JJ
for_IN
clinical_JJ
use_NN
._.

